COVID-19 has been reported to cause AKI, with the proposed pathogenesis of AKI possibly due to a combined direct viral effect through binding of viral proteins to the angiotensin converting enzyme-2 (ACE-2) receptor and a systemic cytokine hyperinflammatory response [23]. This evidence concerns the gene ACE2 and COVID-19.